Evidence map›Paper›PMID 33617503›Full record

ArticleCurrent oncology (Toronto, Ont.)2021

Blood Cholesterol and Outcome of Patients with Cancer under Regular Cardiological Surveillance.

Anna Lena Hohneck, Stephanie Rosenkaimer, Ralf-Dieter Hofheinz, Ibrahim Akin, Martin Borggrefe, Stefan Gerhards

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. A deadly taste: linking bitter taste receptors and apoptosis.Apoptosis : an international journal on programmed cell death · 2025
    Review
  2. Article
  3. Effects of Obesity and Calorie Restriction on Cancer Development.International journal of molecular sciences · 2023
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Anna Lena HohneckUniversity Medical Centre Mannheim, First Department of Medicine (Cardiology), Medical Faculty Mannheim, Heidelberg University, European Centre for AngioScience (ECAS), 68167 Mannheim, Germany.ORCID 0000-0002-7629-2770
Stephanie RosenkaimerUniversity Medical Centre Mannheim, First Department of Medicine (Cardiology), Medical Faculty Mannheim, Heidelberg University, European Centre for AngioScience (ECAS), 68167 Mannheim, Germany.
Ralf-Dieter HofheinzThird Department of Medicine (Oncology), Day Treatment Center (TTZ), Interdisciplinary Tumor Center Mannheim (ITM), Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Ibrahim AkinUniversity Medical Centre Mannheim, First Department of Medicine (Cardiology), Medical Faculty Mannheim, Heidelberg University, European Centre for AngioScience (ECAS), 68167 Mannheim, Germany.
Martin BorggrefeUniversity Medical Centre Mannheim, First Department of Medicine (Cardiology), Medical Faculty Mannheim, Heidelberg University, European Centre for AngioScience (ECAS), 68167 Mannheim, Germany.
Stefan GerhardsUniversity Medical Centre Mannheim, First Department of Medicine (Cardiology), Medical Faculty Mannheim, Heidelberg University, European Centre for AngioScience (ECAS), 68167 Mannheim, Germany.
Heidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular (CV) diseases and cancer share several similarities, including common risk factors. In the present investigation we assessed the relationship between cholesterol levels and mortality in a cardiooncological collective. In total, 551 patients receiving anticancer treatment were followed over a median of 41 (95% CI 40, 43) months and underwent regular cardiological surveillance. A total of 140 patients (25.4%) died during this period. Concomitant cardiac diseases were more common in patients who deceased (53 (37.9%) vs. 67 (16.3%),

Indexed as

Cardiovascular DiseasesNeoplasmsCholesterol, LDLHumansRisk FactorsTriglyceridesCholesterol, LDLTriglyceridescancer related mortalitycardio-oncologycholesterol

Identifiers

PMID33617503
PMCPMC7985794
OpenAlexW3129326222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.